Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001753926-26-000426
Filing Date
2026-03-03
Accepted
2026-03-03 17:14:02
Documents
79
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tlcc-20241231.htm   iXBRL 10-K 2633929
7 EXHIBIT 21.1 ex211_1.htm EX-21.1 18989
8 EXHIBIT 23.1 ex231_2.htm EX-23.1 6434
9 EXHIBIT 31.1 ex311_3.htm EX-31.1 20572
10 EXHIBIT 31.2 ex312_4.htm EX-31.2 21373
11 EXHIBIT 32.1 ex321_5.htm EX-32.1 15930
12 EXHIBIT 32.2 ex322_6.htm EX-32.2 15256
  Complete submission text file 0001753926-26-000426.txt   11753193

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20241231_def.xml EX-101.DEF 420280
3 PRESENTATION tlcc-20241231_pre.xml EX-101.PRE 651573
4 CALCULATION tlcc-20241231_cal.xml EX-101.CAL 117675
5 LABEL tlcc-20241231_lab.xml EX-101.LAB 995111
6 SCHEMA tlcc-20241231.xsd EX-101.SCH 70336
82 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20241231_htm.xml XML 1843635
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55181 | Film No.: 26716405
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)